Should I Buy AMRX Stock in 2026?

Data-driven analysis and honest assessment for Amneal Pharmaceuticals Inc

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $12.43P/E: 57.0

Decision Score

5.0/10

Hold

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)2/10

Very high P/E of 57.0 suggests overvaluation

Growth (20%)5/10

Slow growth of 1%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)10/10

Excellent FCF yield of 11.3%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$12.43

P/E Ratio

57.00

Revenue Growth

0.1%

Profit Margin

0.0%

Market Cap

$4.0B

Dividend Yield

None

How AMRX Compares to Competitors

Understanding how AMRX stacks up against peers helps inform your investment decision.

How AMRX Compares to Peers

Upcoming Events for AMRX

+5 Reasons TO Buy AMRX

1. High free cash flow yield of 11.3%

strong

FCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.

-5 Reasons NOT to Buy AMRX

1. Thin profit margins of 0.0%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

2. Expensive valuation at 57x earnings

medium risk

P/E of 57 is significantly above averages. High expectations leave little room for disappointment.

3. Minimal revenue growth

low risk

Growth of 0.1% barely keeps pace with inflation.

Who Should Buy AMRX?

Investment Profile

Risk Level

High

Recommended Holding Period

3-5 years

Best For:

  • Momentum Traders

    High-growth profile attracts momentum

Not Suitable For:

  • Growth Investors

    Limited 0% growth may disappoint

  • Value Investors

    Premium P/E of 57 doesn't fit value criteria

  • Income-Focused Retirees

    No dividend paid

  • Risk-Averse Investors

    High risk may cause uncomfortable volatility

Consider These Alternatives

If you're interested in AMRX, compare these Health Care peers:

Pro tip: Compare AMRX directly with competitors using our comparison tool to see which stock better fits your criteria.

Get the Full Picture

Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for AMRX

Frequently Asked Questions

What is AMRX stock price today?

AMRX (Amneal Pharmaceuticals Inc) stock is trading at $12.43 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AMRX stock going up or down today?

AMRX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AMRX stock now?

The decision to buy AMRX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AMRX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AMRX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AMRX stock overvalued or undervalued?

AMRX currently trades at a P/E ratio of 57.00, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if AMRX is fairly priced.

What is AMRX's P/E ratio?

AMRX has a price-to-earnings (P/E) ratio of 57.00, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AMRX's market cap?

AMRX (Amneal Pharmaceuticals Inc) has a market capitalization of $4.00 billion, making it a small-cap stock.

What is AMRX's price to book ratio?

AMRX trades at a price-to-book (P/B) ratio of 105.45, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Similar Investment Decisions

Explore investment analyses for stocks similar to Amneal Pharmaceuticals Inc

Explore Categories

Disclaimer

This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.